Mesenchymal stem cells (MSCs) have been widely used in the fields of tissue engineering
and regenerative medicine due to their self-renewal capabilities and multipotential …

The field of gene therapy has evolved over the past two decades after the first introduction of
nucleic acid drugs, such as plasmid DNA (pDNA). With the development of in vitro …

The successful control of coronavirus disease 2019 (COVID-19) pandemic is not only relying
on the development of vaccines, but also depending on the storage, transportation, and …

Synthetic biology seeks to redesign biological systems to perform novel functions in a
predictable manner. Recent advances in bacterial and mammalian cell engineering include …

Seasonal influenza A viruses continue to pose a public health threat, and current vaccines
are not sufficiently effective because of virus mutation. There is an urgent need to develop a …

Background Currently, the overall therapeutic efficiency of mesenchymal stem cells (MSCs)
transplantation for the treatment of cardiovascular disease is not satisfactory. The low …

During the past decades, stem cell‐based therapy has acquired a promising role in
regenerative medicine. The application of novel cell therapeutics for the treatment of …

Myocardial Infarction (MI) is the most common cardiovascular disease. An average-sized MI
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …

Cardiac tissue engineering (CTE) remains a great challenge to construct a cell-inductive
scaffold that has positive effects on cardiac cell behaviors and cardiac tissue repair. In this …

Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal
stem cell (MSC) transplantation is considered a promising approach and has made …